Psychological Outcomes and Interventions for Individuals With Congenital Heart Disease: A Scientific Statement From the American Heart Association
Authors:
- Adrienne H. KovacsAKAdrienne H. Kovacs
- Judith BrouilletteJBJudith Brouillette
- Patricia IbeziakoPIPatricia Ibeziako
- Jamie L. JacksonJJJamie L. Jackson
- Nadine A. KasparianNKNadine A. Kasparian
- Yuli Y. KimYKYuli Y. Kim
- Tracy LivecchiTLTracy Livecchi
- Christina SillmanCSChristina Sillman
- Lazaros K. KochilasLKLazaros K. Kochilas
- on behalf of the American Heart Association Council on Lifelong Congenital Heart DiseaseODon behalf of the American Heart Association Council on Lifelong Congenital Heart Disease
- Heart Health in the YoungHYHeart Health in the Young
- Stroke CouncilSCStroke Council
Top Cited Papers
- 1 August 2022
- journal article
- review article
- Published by Wolters Kluwer Health in Circulation: Cardiovascular Quality and Outcomes
- Vol. 15 (8) , e000110
Abstract
Although resilience and high quality of life are demonstrated by many individuals with congenital heart disease, a range of significant psychological challenges exists across the life span for this growing patient population. Psychiatric disorders represent the most common comorbidity among people with congenital heart disease. Clinicians are becoming increasingly aware of the magnitude of this problem and its interplay with patients’ physical health, and many seek guidance and resources to improve emotional, behavioral‚ and social outcomes. This American Heart Association scientific statement summarizes the psychological outcomes of patients with congenital heart disease across the life span and reviews age-appropriate mental health interventions, including psychotherapy and pharmacotherapy. Data from studies on psychotherapeutic, educational‚ and pharmacological interventions for this population are scarce but promising. Models for the integration of mental health professionals within both pediatric and adult congenital heart disease care teams exist and have shown benefit. Despite strong advocacy by patients, families‚ and health care professionals, however, initiatives have been slow to move forward in the clinical setting. It is the goal of this scientific statement to serve as a catalyst to spur efforts for large-scale research studies examining psychological experiences, outcomes, and interventions tailored to this population and for integrating mental health professionals within congenital heart disease interdisciplinary teams to implement a care model that offers patients the best possible quality of life.Keywords
This publication has 130 references indexed in Scilit:
- Racism and Health IAmerican Behavioral Scientist, 2013
- ADHD Medications and Risk of Serious Cardiovascular Events in Young and Middle-aged AdultsJAMA, 2011
- Resource Use Among Adult Congenital Heart Surgery Admissions in Pediatric HospitalsCirculation: Cardiovascular Quality and Outcomes, 2011
- Clonidine Extended-Release Tablets as Add-on Therapy to Psychostimulants in Children and Adolescents With ADHDPediatrics, 2011
- Best Practices in Managing Transition to Adulthood for Adolescents With Congenital Heart Disease: The Transition Process and Medical and Psychosocial IssuesCirculation, 2011
- Neurobehavioral Abnormalities in Newborns with Congenital Heart Disease Requiring Open-Heart SurgeryThe Journal of Pediatrics, 2011
- Adolescent Outcomes of Childhood Attention-Deficit/Hyperactivity Disorder in a Diverse Community SampleJournal of the American Academy of Child & Adolescent Psychiatry, 2010
- Psychological adjustment and quality of life in children and adolescents following open-heart surgery for congenital heart disease: a systematic reviewBMC Pediatrics, 2009
- Cardiovascular Monitoring of Children and Adolescents With Heart Disease Receiving Medications for Attention Deficit/Hyperactivity DisorderCirculation, 2008
- A Randomized, Double-Blind, Placebo-Controlled Study of Guanfacine Extended Release in Children and Adolescents With Attention-Deficit/Hyperactivity DisorderPediatrics, 2008